PRIMARY CENTRAL NERVOUS SYSTEM TUMOR
Clinical trials for PRIMARY CENTRAL NERVOUS SYSTEM TUMOR explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CENTRAL NERVOUS SYSTEM TUMOR trials appear
Sign up with your email to follow new studies for PRIMARY CENTRAL NERVOUS SYSTEM TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: drug combo trial launches
Disease control Recruiting nowThis study tests a new cancer drug, repotrectinib, combined with standard chemotherapy in children and young adults with advanced solid tumors that have spread. The goal is to find the safest dose and see if the combination can shrink tumors. Researchers will also study how the b…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug PLX038 targets aggressive brain tumors
Disease control Recruiting nowThis study tests a drug called PLX038 in adults with brain or spinal cord tumors, including those with changes in the MYC or MYCN genes. The trial has two phases: first, finding the right dose, then checking if it works. Participants receive PLX038 intravenously every three weeks…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM TUMOR
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for kids with rare cancers: targeted drug repotrectinib enters trial
Disease control Recruiting nowThis study tests a drug called repotrectinib in children and young adults (up to age 25) with advanced solid tumors, lymphoma, or brain tumors that have specific gene changes (ALK, ROS1, or NTRK1-3). The goal is to find the safest dose and see if the drug shrinks tumors. Particip…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Turning Point Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can proton radiation save Kids' brainpower? new study aims to find out
Knowledge-focused Recruiting nowThis study will test whether computer-based thinking assessments are practical for children aged 4 to 21 with brain tumors who are receiving proton beam radiation therapy. Researchers will measure thinking skills before, during, and after treatment to see how radiation affects me…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM TUMOR
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC